News & Perspective

Dec 19, 2011

Dec 19, 2011

Signs of Tamiflu-resistant 2009 H1N1 flu transmission cited

(CIDRAP News) – An analysis of 2009 H1N1 influenza virus isolates from the 2010-11 flu season suggests that low-level community transmission of an oseltamivir-resistant strain took place, a development that bears close watching, researchers reported today.

Oct 18, 2011

Oct 18, 2011

Anthrax countermeasures better than in 2001, but work remains

(CIDRAP News) – If someone tried to kill Americans with Bacillus anthracis spores today, the nation would have a better medical tool chest for treating the sick and those potentially exposed than it had 10 years ago, when the anthrax letter attacks killed five people, but anthrax defenses are still a work in progress.

Oct 03, 2011

Oct 03, 2011

WHO: Keep current strains in 2012 Southern Hemisphere flu vaccine

(CIDRAP News) – A run of stability in the makeup of seasonal influenza vaccines continued as the World Health Organization (WHO) recently recommended using the same three flu strains in next year's Southern Hemisphere vaccine as are in the current Northern Hemisphere vaccine and were used last year in southern countries.

Aug 26, 2011

Aug 26, 2011

Australia reports oseltamivir-resistant 2009 H1N1 cluster

(CIDRAP News) – Australian public health officials yesterday reported a cluster of oseltamivir (Tamiflu)-resistant 2009 H1N1 infections, one of the largest to date, centered in one region of New South Wales state.

Jul 13, 2011

Jul 13, 2011

Study: Adjuvanted H1N1 vaccines had little effect on GBS risk

(CIDRAP News) – A five-country study from Europe indicates that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barre syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»